Ketsch, Germany

Bernd Rapp

This inventor holds 1 USPTO granted patent. Top assignee: Rutgerswerke Aktiengesellschaft. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Rapp. Retrieved from https://idiyas.com/inventor/bernd-rapp-9ksmpgcu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernd Rapp: Innovator in Chemical Processes

Introduction

Bernd Rapp is a notable inventor based in Ketsch, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of quinuclidine-3-methanol. His innovative processes have implications in the pharmaceutical industry, especially in the development of antihistaminic drugs.

Latest Patents

Bernd Rapp holds 1 patent for his work titled "Preparation of quinuclidine-3-methanol." This patent describes a detailed process involving the reaction of quinuclidine-3-one acid addition salt with alkali metal cyanide in aqueous media. The process further includes several steps that lead to the production of quinuclidine-3-methanol, which serves as an intermediate for the antihistaminic drug mequitazine.

Career Highlights

Rapp is associated with Rutgerswerke Aktiengesellschaft, where he has been able to apply his expertise in chemical processes. His work has not only advanced the understanding of quinuclidine derivatives but has also contributed to the broader field of medicinal chemistry.

Collaborations

Throughout his career, Bernd Rapp has collaborated with esteemed colleagues such as Josef Gotz and Winfried Orth. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Bernd Rapp's contributions to the field of chemistry, particularly through his patent on quinuclidine-3-methanol, highlight his role as an innovator. His work continues to influence the development of important pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…